CHINA LEX PHARMA NEWSLETTER
Vol. 1, No. 23 - October 25, 2000
Lehman, Lee & Xu
China Lawyers, Notaries, Patent, Copyright and Trademark Agents
(formerly known as the L&A Law Firm)
mail@chinalaw.cc
Contact Our Other Offices:
shanghai@chinalaw.cc - shenyang@chinalaw.cc - tianjin@chinalaw.cc - guangzhou@chinalaw.cc - dalian@chinalaw.cc
Drug E-Commerce Rules Issued
The Chinese State Drug Administration issued the Rules on Administration of Drug E-Commerce on June 26, 2000 and recently made the Rules available to the public.
Under the Rules, the government agencies in charge drug e-commerce are drug administrations, information industry departments and administrations of industry & commerce at central and local levels. The Rules have 7 chapters and 33 articles, under which the requirements for drug e-commerce Web sites and drug manufacturers/trading companies selling drugs through drug Web sites are set forth.
In addition to the normal registration requirements for any e-commerce companies, the establishment of drug e-commerce Web sites requires the approval of State Drug Administration.
Source: Studies on Drug Administration
LEHMAN LEE PROVIDES A FULL RANGE OF CHINA ANTI-COUNTERFEITING SERVICES, INVESTIGATIONS, ADMINISTRATIVE AND JUDICIAL ENFORCEMENT
CONTACT US AT mail@chinalaw.cc
Tel: 8610-6532-3861; Fax: 8610-6532-3877
Web site for Doctors Established
A new joint venture in the online medical sector, Swiss Life Tsinghua Co., was incorporated jointly by the Swiss Life China Investment Fund and Tsinghua Tongfang Co.
The new medical Web site is named iHospital.com.cn and is reported to be the first Web site for doctors in China.
Swiss Life China Investment Fund is sponsored by Swiss Life and Pension Insurance and is managed by Jardine Fleming Investment Management Ltd. The Tsinghua Tongfang Co. is an IT company affiliated with the Tsinghua University, China's MIT.
Source: China Insurance News
Looking to build your web presence in China?
design@distilleddesign.com
Web Design | Information Architecture | Hosting | Chinese Language Support | Strategy and Consultation
Johnson & Johnson Donates US$6M to China
Johnson & Johnson will donate RMB 50 million (US$6.04 million) in the next five years toward cooperative programs of China's medical and health care sectors with the Chinese Ministry of Health and State Drug Administration.
Johnson & Johnson recently signed an agreement with the two government agencies. This project is China's largest health care project with non-governmental financial aid. The money will help China's medicine, health care sectors to improve professional training, education, and drafting of pharma laws.
Source: China Business News
Contact Lehman Lee's Pharma Practice Group
Product Registrations, Anti-Counterfeiting, Import/Export Restrictions, OTC, Mergers & Acquisitions
mail@chinalaw.cc
Tel: 8621-6375-8240; Fax: 8621-6375-8705
China Lawyers, Notaries, Patent, Copyright and Trademark Agents
(formerly known as the L&A Law Firm)
Suite 188, Beijing International Club
21 Jianguomenwai Dajie, Beijing 100020 China
Tel.: (86)(10) 6532-3861
Fax: (86)(10) 6532-3877
mail@chinalaw.cc
http://www.chinalaw.cc/
Contact Our Other Offices:
shanghai@chinalaw.cc - shenyang@chinalaw.cc - tianjin@chinalaw.cc - guangzhou@chinalaw.cc - dalian@chinalaw.cc
The China Lex Pharma Newsletter is intended to be used for news purposes only. It should not be taken as comprehensive legal advice, and Lehman, Lee & Xu will not be held responsible for any such reliance on its contents.
